[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2024,74(3):229-263. [2] LI Y,FENG A,ZHENG S,et al.Recent estimates and predictions of 5-year survival in patients with gastric cancer:A model-based period analysis[J].Cancer Control,2022,29:10732748221099227. [3] ZHU X,GE B,WEN L,et al.Analysis of multiple factors influencing the survival of patients with advanced gastric cancer[J].Aging,2024,16(10):8541-8551. [4] MA X,JIA S,WANG G,et al.TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance[J].Sig Transduct Target Ther,2023,8(1):246. [5] 罗琴,丁爱娇,姜冰洁.胃癌组织中肿瘤相关巨噬细胞CD68、PD-L1表达与胃癌预后情况分析[J].系统医学,2023,8(22):27-30. LUO Q,DING A J,JIANG B J.Analysis of tumor-associated macrophage CD68 and PD-L1 expression in gastric cancer tissues and prognosis of gastric cancer[J].Syst Med,2023,8(22):27-30. [6] 王雪媛,付福山.PI3K/AKT介导PD-L1基因在人胃癌细胞中的表达[J].基因组学与应用生物学,2019,38(10):4842-4846. WANG X Y,FU F S.Induction of PD-L1 expression by PI3K/AKT signaling pathway in gastric cancer[J].Genom Appl Biol,2019,38(10):4842-4846. [7] SUN J,ZHAO Z,LU J,et al.The tumor microenvironment mediates the HIF-1α/PD-L1 pathway to promote immune escape in colorectal cancer[J].Int J Mol Sci,2024,25(7):3735. [8] DING X C,WANG L L,ZHANG X D,et al.The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia[J].J Hematol Oncol,2021,14(1):92. [9] BAILEY C M,LIU Y,LIU M,et al.Targeting HIF-1α abrogates PD-L1-mediated immune evasion in tumor microenvironment but promotes tolerance in normal tissues[J].J Clin Investig,2022,132(9):e150846. [10] OZCAN G.The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer:Future directions for therapeutic targeting[J].Front Cell Dev Biol,2023,11:1082057. [11] UCARYILMAZ METIN C,OZCAN G.The HIF-1α as a potent inducer of the hallmarks in gastric cancer[J].Cancers,2022,14(11):2711. [12] 刘燕翔,张锦,郑玉双,等.PGC-1α、HIF1A在胃癌中的表达与临床病理特征及预后的关系[J].胃肠病学和肝病学杂志,2024,33(6):709-713. LIU Y X,ZHANG J,ZHENG Y S,et al.Correlation of PGC-1α and HIF1A expression with the clinicopathological features and prognosis in gastric cancer[J].Chin J Gastroenterol Hepatol,2024,33(6):709-713. [13] 韩轮,马艳飞.芒柄花素调节HIF-1α/VEGF信号通路对胃癌细胞增殖、凋亡和肿瘤血管生成拟态的影响[J].国际消化病杂志,2023,43(5):297-303. HAN L,MA Y F.Effects of formononetin on proliferation and apoptosis of gastric cancer cells and tumor vasculogenic mimicry by regulating HIF-1α/VEGF signaling pathway[J].Int J Dig Dis,2023,43(5):297-303. [14] HALMA M T J,TUSZYNSKI J A,MARIK P E.Cancer metabolism as a therapeutic target and review of interventions[J].Nutrients,2023,15(19):4245. [15] TANG K,TOYOZUMI T,MURAKAMI K,et al.HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway[J].Br J Cancer,2022,127(3):474-487. [16] 李丽,叶宗媛,王健,等.胃癌中CMTM6和PD-L1的表达及其临床意义[J].临床与实验病理学杂志,2023,39(1):68-73. LI L,YE Z Y,WANG J,et al.Expression of CMTM6 and PD-L1 in gastric cancer and its clinical significance[J].Chin J Clin Exp Pathol,2023,39(1):68-73. [17] 赵鸿鹰,江荣科,李艳芳,等.PD-L1反义寡核苷酸纳米颗粒对胃癌细胞侵袭和免疫因子分泌作用[J].中国药师,2022(12):2067-2073. ZHAO H Y,JIANG R K,LI Y F,et al.Effects of PD-L1 antisense oligonucleotide nanoparticles on the invasion and immune factor secretion of gastric cancer cells[J].China Pharm,2022(12):2067-2073. [18] CHEN Z Q,ZUO X L,CAI J,et al.Hypoxia-associated circPRDM4 promotes immune escape via HIF-1α regulation of PD-L1 in hepatocellular carcinoma[J].Exp Hematol Oncol,2023,12(1):17. [19] 蒋豆豆,董佳文,胡德胜,等.乏氧条件下HIF-1α通过上调PD-L1促进鼻咽癌恶性发展的机制[J].肿瘤防治研究,2021,48(6):570-575. JIANG D D,DONG J W,HU D S,et al.Mechanism of HIF-1α promoting malignant development of nasopharyngeal carcinoma by upregulating PD-L1 under hypoxic conditions[J].Cancer Res Prev Treat,2021,48(6):570-575. [20] 李昂,查文章,轩福明,等.缺氧微环境下HIF-1α通过PD-L1调控肝癌恶性生物学行为和上皮间质转化的机制研究[J].安徽医药,2025,29(1):189-195,218. LI A,ZHA W Z,XUAN F M,et al.HIF-1α regulates malignant biological behavior and epithelial interstitial transformation of hepatocellular carcinoma through PD-L1 in hypoxia microenvironment[J].Anhui Med Pharm J,2025,29(1):189-195,218. [21] XU X,CHEN J,LI W,et al.Immunology and immunotherapy in gastric cancer[J].Clin Exp Med,2023,23(7):3189-3204. |